Effect of thiamine on lipid profile in diabetic rats

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 3, 2009, Pages 165-168

  Naveed, Abdul Khaliq ^a   Qamar, Tehmina ^a   Ahmad, Ijaz ^a   Raheem, Amina ^a   Malik, Maujid Masood ^a  

^a ARMY MEDICAL COLLEGE   (Pakistan)

Author keywords

Diabetes mellitus; Dyslipidemia; Glycosylated HbA1c; Hyperglycemia; Sprague Dawley rats

Indexed keywords

ALLOXAN; GLUCOSE OXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; THIAMINE; TRIACYLGLYCEROL;

ALBINISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MEGADOSE; DYSLIPIDEMIA; EXPERIMENTAL STUDY; GLUCOSE BLOOD LEVEL; INTERVENTION STUDY; MALE; NONHUMAN; PAKISTAN; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; HYPERGLYCEMIA; LIPIDS; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIAMINE;

EID: 64149097060     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nishtar S, Shera S, Rafique G, Mohammad KB, Ahmed A. Diabetes prevention and control: national action plan for NCD prevention, control and health promotion in Pakistan. J Pak Med Assoc 2004; 54(12 Suppl 3):S26-30.
2. Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H. Pakistan national diabetes survey: prevalence of glucose intolerance and associated factors in Shikarpur, Sindh province. Diabet Med 1995; 12:1116-21.
3. Shera AS, Rafique G, Khawaja IA, Baqai S, Khan IA, King H, et al. Pakistan national diabetes survey prevalence of glucose intolerance and associated factors in North-West Frontier Province (NWFP) of Pakistan. J Pak Med Assoc 1999; 49:206-11.
4. Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan national diabetes survey: prevalence of glucose intolerance and associated factors in Baluchistan province. Diabet Res Clin Pract 1999; 44:49-58.
5. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type-2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405-12.
6. UK. Department of Health. National service framework for diabetes: delivery strategy. London: Department of Health, 2002; 1-40.
7. Abbas S, Abbas S. Lipid-lowering effect of Atorvastatin in patients with type-2 diabetes mellitus. Pak Armed Forces Med J 2004; 54:170-5.
8. Rumberger JM, Wu T, Hering MA, Marshall S. Role of hexosamine biosynthesis in glucose-mediated up-regulation of lipogenic enzyme mRNA levels; effects of glucose, glutamine, and glucosamine on glycerophosphate dehydrogenase, fatty acid synthase, and acetyle-CoA carboxylase mRNA levels. J Biol Chem 2003; 278:28547-52.
9. Veerababu G, Tang J, Hoffman RT, Daniels MC, Hebert LF Jr., Crook ED, et al. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity and impaired glucose tolerance. Diabetes 2000; 49:2070-8.
10. Babaei-Jadidi R, Karachalias N, Battah S, Ahmed N, Thornalley PJ. Prevention of incipient diabetic nephropathy by high dose thiamine and benfotiamine. Diabetes 2003; 52:2110-20.
11. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type-2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63:225-32.
12. Pekovich SR, Martin PR, Singleton CK. Thiamine deficiency decreases steady-state transketolase and pyruvate dehydrogenase but not alpha-ketoglutarate dehydrogenase mRNA levels in three human cell types. J Nutr 1998; 128:683-7.
13. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura. T, Ju Q, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9:294-9.
14. Khosla P, Gupta DD, Nagpal RK. Effect of trigonella foenum graecum (Fenugreek) on blood glucose in normal and diabetic rats. Indian J Pharmacol 1995; 39:173-4.
15. Rodriguez-Moran M, Guerrero-Rmero F. Increased levels of C-reactive protein in noncontrolled type-II diabetic subjects. J Diabet Compl 1999; 13:211-5.
16. Mallia AK, Hermanson GT, Kron RJ, Fujimoto EK, Smith PK. Determination of total glycated HbA1c in blood. Anal Lett 1981; 14:649-61.
17. National Cholesterol Education Program. Executive summary of the third report. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adults treatment panel 111). JAMA 2001; 285:2486.
18. Young DS, Friedman RB. Effects of disease on clinical laboratory tests. 04th ed. New York: American Association of Clinical Chemistry AACC, 2001.
19. Assman G. Lipiddiagnostik heute. in Greten H, et al. Lipoproteine and Herzinfarkt. Baden,Germany Witzstrock-Verlag. Baden; 1979.p.29ff.
20. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ. High dose thiamine therapy counters dyslipidemia in streptozotocin-induced diabetic rats. Diabetologia 2004; 47: 2235-46.
21. Wrinkler G, Pal B, Nagybeganyi E, Ory I, Porochnavec M, Kempler P. Arzneimittelforschung. Drug Res 1999; 49:220-4.
22. Owu DU, Antai AB, Udofia KH, Obembe AO, Obasi KO, Eteng MU. Vitamin C improves basal metabolic rate and lipid profile in alloxan induced diabetes mellitus in rats; J Biosci 2006; 31: 575-79.
23. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc-Diabetol 2005; 4:5.